Arvinas Inc. (NASDAQ:ARVN) is one of the best small cap stocks with biggest upside potential. On August 8, Arvinas, in ...

Pfizer (NYSE: PFE) reported that its Phase III THRIVE-131 study of inclacumab, an experimental P-selectin inhibitor for ...

A declining stock price amid steadily rising payouts means Realty Income stock offers an above-average yield of 5.5% at ...

Let’s take a closer look at a few biotech stocks poised to benefit from this resurgence. Medicus Pharma Ltd. (NASDAQ: MDCX) is an emerging biotech and life sciences company with a global footprint ...

This is the latest hit for Pfizer’s sickle cell disease portfolio after pulling Oxbryta from the market in 2024.

Inclacumab, which Pfizer obtained in its 2022 acquisition of Global Blood Therapeutics, failed to significantly lower pain ...

Less than a year after it was forced to withdraw GBT's sickle cell disease (SCD) therapy Oxbryta from all world markets after ...

Pfizer set about evaluating inclacumab in pair of phase 3 studies, dubbed Thrive. The Big Pharma terminated one of those ...

Cha Vaccine Institute said Monday it has appointed its R&D chief Han Seung-il as its new CEO. Han, an industry veteran who ...

There has been a continued uptick in speculative trading led by retail investors, Goldman Sachs' trading desk says. See the favorite stocks.

News dell'ultima ora dall'Italia e dal mondo. Notizie, video, rubriche e approfondimenti su Sport, Cronaca, Economia, Politica, Salute e tanto altro ...

The Lake Havasu City Council on Tuesday voted to spend $2.7 million on the purchase of 34 city vehicles and the refurbishment ...